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Background: CTCF is a highly conserved and essential zinc finger protein expressed in virtually all cell types. In
conjunction with cohesin, it organizes chromatin into loops, thereby regulating gene expression and epigenetic
events. The function of CTCFL or BORIS, the testis-specific paralog of CTCF, is less clear.
Results: Using immunohistochemistry on testis sections and fluorescence-based microscopy on intact live
seminiferous tubules, we show that CTCFL is only transiently present during spermatogenesis, prior to the onset of
meiosis, when the protein co-localizes in nuclei with ubiquitously expressed CTCF. CTCFL distribution overlaps
completely with that of Stra8, a retinoic acid-inducible protein essential for the propagation of meiosis. We find that
absence of CTCFL in mice causes sub-fertility because of a partially penetrant testicular atrophy. CTCFL deficiency
affects the expression of a number of testis-specific genes, including Gal3st1 and Prss50. Combined, these data
indicate that CTCFL has a unique role in spermatogenesis. Genome-wide RNA expression studies in ES cells
expressing a V5- and GFP-tagged form of CTCFL show that genes that are downregulated in CTCFL-deficient testis
are upregulated in ES cells. These data indicate that CTCFL is a male germ cell gene regulator. Furthermore,
genome-wide DNA-binding analysis shows that CTCFL binds a consensus sequence that is very similar to that of
CTCF. However, only ~3,700 out of the ~5,700 CTCFL- and ~31,000 CTCF-binding sites overlap. CTCFL binds
promoters with loosely assembled nucleosomes, whereas CTCF favors consensus sites surrounded by phased
nucleosomes. Finally, an ES cell-based rescue assay shows that CTCFL is functionally different from CTCF.
Conclusions: Our data suggest that nucleosome composition specifies the genome-wide binding of CTCFL and
CTCF. We propose that the transient expression of CTCFL in spermatogonia and preleptotene spermatocytes serves
to occupy a subset of promoters and maintain the expression of male germ cell genes.
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Three-dimensional folding of the eukaryotic genome
occurs in a highly organized manner so as to compact
chromatin while allowing temporal and spatial expression
of genes. The genome contains regulatory elements, such
as promoters, enhancers, locus control regions, insulators
and enhancer blockers, that can orchestrate chromatin
folding and gene activity over short and long distances,
both in cis and in trans [1]. CTCF is a key coordinator of
three-dimensional chromatin structure, allowing loop for-
mation and specific chromatin compositions [2,3]. Gene
activity is controlled in a positive or negative manner de-
pending on the regulatory sequences present in the loops
that are formed. The importance of CTCF in chromatin
organization is emphasized by its evolutionary conserva-
tion, its ubiquitous expression, and its essential role in vir-
tually all cells and tissues examined [4,5]. Hence, CTCF
has been termed the “master weaver” of the genome [3].
The genome-wide binding by CTCF has been studied
by different groups (see, for example, [6-10]). This has
revealed ~35,000 CTCF-binding sites in the mammalian
genome, of which more than 70% are shared between cell
types. A relatively long consensus-binding motif for CTCF
has been determined, which displays variability when
compared to sites of transcription factors like KLF4,
SOX2 and MYC [7]. The majority of CTCF binding-sites
are found near genes, and ~8% is in the vicinity of tran-
scription start sites (TSSs). Arrays of positioned (or
“phased’) nucleosomes are found surrounding the
nucleosome-free CTCF-binding sites [11-13], suggesting
that CTCF binding promotes the ordered positioning of
histones in its vicinity. CTCF has also been proposed to
regulate the positioning of variant histones, such as H2A.
Z [6,14]. Interestingly, the cohesin complex binds at the
same position as CTCF in a CTCF-dependent manner.
Together with CTCF, cohesin is essential for a proper
three-dimensional chromatin structure and correct gene
regulation [15-17].
CTCF-dependent loop formation is of crucial import-
ance at imprinted loci. A well-studied example is the
imprinted Igf2-H19 locus, in which Igf2 is expressed
from the paternal and H19 from the maternal allele [18].
The imprinting control region (ICR) located in between
the Igf2 and H19 genes is methylated on the paternal al-
lele, preventing CTCF binding. As a result the enhancer
downstream of the H19 gene can interact with the Igf2
promoter and drive expression of this gene. On the non-
methylated maternally derived ICR, CTCF does bind,
thereby preventing enhancer-Igf2 interaction, resulting
in a chromatin loop that allows enhancer-H19 associ-
ation and H19 expression. By binding the ICR, CTCF
therefore acts as a regulator of imprinted sites.
The CTCF-like (CTCFL) protein, or Brother Of the
Regulator of Imprinted Sites (BORIS) [19], has a centraldomain of 11 zinc fingers (ZFs) that is very similar to
that of CTCF and that is essential for DNA binding. The
N- and C-terminal domains of CTCF and CTCFL are
not homologous. CTCFL is less conserved across spe-
cies, and the protein arose later in evolution, as it is
detected in amniotes only [20]. Furthermore, expression
of CTCFL is restricted to testis, several types of cancers
and a number of cell lines [21-23].
Studies of CTCF and CTCFL protein distribution in
the testis have yielded contradictory results. Initially, a
mutually exclusive expression pattern of CTCFL and
CTCF was described [19], with CTCF being present in
round spermatids (i.e. after meiosis) and CTCFL in pri-
mary spermatocytes (i.e. during meiotic prophase).
Surprisingly, CTCFL was reported to be more abundant
in the spermatocyte cytoplasm than in the nucleus. This
led to the hypothesis that during germ cell development,
CTCFL substitutes for the absence of CTCF and might be
involved in reprogramming of DNA methylation in the
male germ line. CTCFL was later reported to be present
in gonocytes during embryonic development and, after
birth, in spermatogonia, whereas CTCF was reported to
localize to the supporting Sertoli cells [24]. In the same
study CTCFL, together with the protein methyltransferase
PRMT7, was suggested to regulate DNA methylation of
imprinted genes in the male germline. However, defects in
imprinting often result in embryonic phenotypes [25],
whereas Ctcfl knockout mice were shown to display a
phenotype only in the testis [26]. Recently, enrichment of
Ctcfl mRNA in round spermatids was reported, adding
perplexity to the localization and expression of CTCFL
[26,27].
While the whole genome DNA-binding profile for
CTCF has been elucidated, this has not been done for
CTCFL. It therefore remains unclear how CTCFL binding
relates to that of CTCF. In addition, it is unknown how
these proteins are related functionally and mechanistically.
To address these issues, we examined CTCFL function
and localization with respect to CTCF, and identified the
genome-wide binding sites of CTCFL and CTCF. We
show that CTCF and CTCFL are functionally different
proteins that co-localize within the nuclei of pre-meiotic
germ cells. CTCFL acts as a male germ cell gene regulator,
preferably binding near promoters with active chromatin
marks. Interestingly, CTCF and CTCFL bind a highly
similar DNA motif; nevertheless, only two-third of the
~5,700 CTCFL-binding sites are bound by CTCF. Con-
versely, the vast majority of CTCF sites are not bound by
CTCFL. We find that nucleosome composition specifies
CTCF and CTCFL binding. In contrast to CTCF, CTCFL
associates with relatively “open” chromatin, and we
propose that CTCFL promotes the maintenance of the
epigenetic state of a subset of gene promoters and hence
gene expression during spermatogenesis.
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CTCFL and CTCF co-localize transiently in pre-meiotic
male germ cells
To resolve the localization of CTCF and CTCFL in testis,
and to address CTCFL function, we generated Ctcfl knock-
out and GFP-CTCF- and GFP-CTCFL-expressing knockin
mice. To obtain information about the organization of the
Ctcfl gene, we mapped its 5’ end and examined Ctcfl ex-
pression (Figure 1A, B). We next generated three separate
alleles using homologous recombination in ES cells: a Ctcfl
knockout allele (Ctcfldel), in which exons 1–8 of the Ctcfl
gene are deleted, and Ctcfl and Ctcf knockin alleles (Ctcflgfp
and Ctcfgfp, respectively), to express GFP-CTCFL and GFP-
CTCF instead of CTCFL and CTCF, respectively
(Figure 1C-I).
Mice were generated, and the distribution of CTCFL
was investigated by immunocytochemistry in sections of
seminiferous tubules from wild-type and Ctcfl knockout
mice. CTCFL was present in wild-type testis in cells lin-
ing the basal lamina (Figure 2A, B). Not all cells lining
the lamina were CTCFL-positive, and in some tubules
no CTCFL-positive cells were detected. Importantly, no
signal was detected on sections derived from CTCFL-
deficient mice (Figure 2C, see also Figure 2F), showing
that the
CTCFL staining in wild-type sections is specific. The
localization of the CTCFL-positive cells in the basal
compartment of the seminiferous tubules indicates that
these cells are spermatogonia or preleptotene spermato-
cytes, as only upon progression in meiotic prophase do
spermatocytes become disconnected from the basal lam-
ina and move through the Sertoli cell barrier into the
adluminal compartment of the seminiferous tubules.
The localization of CTCFL appeared reminiscent of
STRA8 (STimulated by Retinoic Acid), which is expressed
transiently from B spermatogonia to preleptotene sperma-
tocytes and is essential for retinoic acid-induced commit-
ment to meiosis [29-32]. An absolute overlap between
STRA8 and CTCFL was confirmed using dual-color im-
munofluorescence (Figure 2D, E). Immunofluorescent
staining experiments did not reveal an obvious change in
the number of STRA8-positive tubules in CTCFL-
deficient testis (Figure 2E, G, and data not shown). Thus,
absence of the CTCFL signal in Ctcfl knockout sections is
not due to the disappearance of a cell type.
To confirm CTCFL localization and compare its distribu-
tion to that of CTCF, we next analyzed expression and
localization of the two proteins ex vivo. We isolated intact
seminiferous tubules from the testes of Ctcflgfp and Ctcfgfp
male mice, which were injected with Hoechst via the rete
testis to stain nuclei of cells at the adluminal compartment
of the tubule. We then visualized GFP-CTCF(L) and Hoechst
concomitantly using a multiphoton confocal laser scanning
microscope setup [33]. Three-dimensional reconstruction ofimages taken longitudinally through the seminiferous tubules
yielded an organizational view of the tubule, and the position
and type of the GFP-positive cells (Figure 2H-P). GFP-
CTCFL was detected in the nucleus of clustered cells repre-
senting a minor fraction of the total testis tubule (Figure 2H-
m, and Additional file 1: Movie S1). These cells stained nega-
tive for Hoechst, and since the luminally injected Hoechst
does not cross the Sertoli cell barrier, the GFP-CTCFL-
positive cells must reside on the basal side of this barrier. Ser-
toli cells, which form the tight junctions of the Sertoli cell
barrier, were Hoechst-positive (Figure 2I, J, L, M and Add-
itional file 1: Movie S1). Primary spermatocytes pass this bar-
rier in the preleptotene and leptotene stage [34]. Based on
Hoechst staining, morphology, size and location, we con-
clude that the GFP-CTCFL positive cells represent spermato-
gonia and preleptotene spermatocytes. The ex vivo GFP/
Hoechst results obtained in live tissue are consistent with
our data obtained in fixed paraffin-embedded sections of the
testis stained with the CTCFL antibodies (Figure 2A-C). To-
gether with the STRA8 colocalization data, they strongly
suggest that in the adult testis CTCFL is transiently
expressed in late spermatogonia and preleptotene germ cells.
In contrast to GFP-CTCFL, GFP-CTCF was present in
the nucleus of all cell types of the seminiferous tubule, in-
cluding all germ cells prior to spermiogenesis (Figure 2N-
P, and data not shown). GFP-CTCF was also expressed in
round spermatids, albeit at lower levels. This is consistent
with a primary role for CTCF in cells with histone-based
chromatin. Thus, live imaging in seminiferous tubules
shows that CTCF and CTCFL are co-expressed within late
spermatogonia and preleptotene spermatocytes. Measure-
ment of GFP fluorescence intensities indicate that in cells
where both proteins are expressed, the level of CTCF is
somewhat higher than that of CTCFL.
CTCFL is important for spermatogenesis
To study the role of CTCFL in the male germ line, we
analyzed Ctcfldel/+ and Ctcfldel/del mice. These mice
demonstrated no gross phenotypic defects and appeared
normal. Heterozygous and homozygous Ctcfldel females
showed normal fertility and yielded offspring with
expected ratios (data not shown), consistent with a role
for CTCFL in spermatogenesis only. Heterozygous
Ctcfldel/+ males generated offspring, and demonstrated
normal fertility (Table 1). However, homozygous Ctcfldel
male littermates generated offspring in only half (14 out of
27) of the breedings (Table 1). Breeding with Ctcfldel/del
males yielded significantly (p=0.01; chi test) fewer litters
than Ctcfldel/+ males, but not a different litter size
(p=0.11; t-test). These data indicate that CTCFL is im-
portant for male fertility.
To further investigate the CTCFL deficiency, we weighed
testes from 90-day-old Ctcfldel/del and Ctcfldel/+ mice and
plotted weight distributions. We found that, on average, the
Figure 1 Ctcfl and Ctcf expression and targeting. A, B RNAse protection analysis of Ctcfl and Ctcf. For Ctcfl (A) RNase protection analysis
(RPA) was performed on polyA purified mRNA with probes covering parts of Ctcfl exon 8 and 9 (left, small fragment) or a 5’end RACE product
(right, large fragment). For Ctcf (B) the RPA was performed on total RNA with probes protecting Ctcf exon 2. The positions of the respective
protected fragments are indicated with arrows. Ctcfl mRNA mRNA can only be detected in polyA purified mRNA from testis (t), whereas Ctcf is
identified in total RNA from all three tissues tested. M, marker; p, input probe; c, tRNA control; h, heart; t, testis; b, brain. Aprt exon 3 is used as
loading control and marked by an asterisk [28]. This analysis identifies the first exon containing the ATG translation initiation codon in Ctcfl and
shows that Ctcfl is expressed in testis. C Schematic overview of the modified Ctcfl alleles and targeting constructs. The Ctcfl locus is shown on
scale, with the constructs (not on scale) used for homologous recombination in ES cells underneath. Targeting at the 5’end of Ctcfl yielded the
Ctcfl gpf- neo allele. Cre-mediated excision of the LoxP-embedded neomcyin resistance gene yielded the Ctcfl gfp allele (not shown). The 3’end
targeting was performed on the Ctcfl gpf- neo allele, and yielded the Ctcfl gfp-neo-puro allele. Cre-mediated excision of the sequence in between the
outermost LoxP sites yielded the Ctcfl del allele, in which exons 1–8 of the Ctcfl gene are deleted (not shown). A major difference between the
Ctcfl del allele described here and the Ctcfl knockout published earlier [26] is that in the Ctcfl del allele the GFP coding sequence is fused in frame
with the CTCFL coding sequence. Black boxes represent exons, GFP tag, neomycin and puromycin cassettes. Probes a, b, c, d and e are indicated
by lines. Oligos 1, 2, 3 and 4 are represented by arrowheads. White triangles are LoxP sites. B= BglII; N=NcoI; S= SpeI; A=AvrII. D DNA blot
showing Ctcfl targeting. Probes a and b were used on DNA blots from ES cells for identification of the Ctcflgfp-neo allele and probes c and d for
the Ctcflpuro allele. Probe e identifies the Ctcfldel allele from Ctcflgfp-neo-puro mice that were crossed to a chicken Actin-Cre transgene. Probe a,
HindIII digest (wt 8.9 kb, ko 5.7 kb); probe b, EcoRI digest (wt 14 kb; ko 11 kb); probe c, BamHI digest (wt 16.1 kb; ko 6.8 kb); probe d, BamHI
digest (wt 16.1 kb; ko 11.1 kb). E Absence of Ctcfl DNA in the Ctcfl del allele. PCR on tail DNA indicates that Ctcfl del/del mice are deleted for exons
1–8 (top three panels) and are positive for GFP (oligos 2 and 4). F Absence of Ctcfl RNA in Ctcfl mutant mice. PCR on cDNA derived from testis
mRNA shows that Ctcfl is absent from Ctcfl del/del mice. Acrosin and Gapd function as positive controls. G Schematic overview of the Ctcf allele
and targeting strategy for the Ctcf gfp-neo allele. The Ctcf locus is shown on scale, with the construct (not on scale) used for homologous
recombination in ES cells underneath. Cre-mediated excision of the LoxP-embedded neomcyin resistance gene yielded the Ctcf gfp (or Ctcf ki)
allele (not shown). Black boxes represent exons, GFP tag and neomycin cassette. Oligos 5, 6, 7 and 8 are represented by arrowheads. White
triangles are LoxP sites. E= EcoRI. H PCR confirming Ctcf gpf-neo allele. Identification of the CTCFgfp-neo (or Ctcf ki) allele by PCR with oligos 7 and 8
or oligos 5, 6 and 8 (see panel G). I Western blot confirming GFP-CTCF expression from the Ctcf gfp allele. We isolated MEFS from E13.5 day
wild-type (+/+), heterozygous Ctcf gfp/+ (or Ctcf ki/+) or homozygous Ctcf gfp/gfp (or Ctcf ki/ki) embryos, and identified the GFP-CTCF fusion protein
by Western blot of MEF extracts using anti-CTCF or anti-GFP antibodies. Note the increased size of the GFP-CTCF protein compared to the CTCF
protein due to the GFP tag.
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Figure 2 Expression of CTCFL and CTCF in the testis. A-C Immunohistochemical staining of testis sections. Paraffin-embedded sections from
day 90 testes from heterozygous (del/+) and homozygous (del/del) Ctcfl mutant mice were stained with anti-CTCFL, followed by
diaminobenzidine (DAB) coloring. Some of the CTCFL-positive cells are indicated with black arrowheads. Scale bars A, C: 100 μm, B: 50 μm. D-G
Immunofluorescence staining of testis sections. Sections as described in A-C were stained with CTCFL (D and F) or STRA8 (E and G) antibodies.
STRA8-positive cells in panels E and G are indicated with green arrowheads; the same cells are indicated with red arrowheads in the sections
stained with anti-CTCFL antibodies (panels D and F). In Ctcfl mutant mice, STRA8 distribution is not changed. Scale bar is 50 μm. H-P Ex vivo
confocal and multiphoton imaging of intact seminiferous tubules. Testis tubules were dissected from GFP-CTCFL- (H-M) or GFP-CTCF- (N-P)
expressing mice, exposed to Hoechst at the adluminal side of the seminiferous tubule, and analyzed with a confocal/multiphoton microscope
(GFP-CTCFL and GFP-CTCF, green; Hoechst, red). Panel H-J (see also Movie S1) shows a low magnification view of GFP-CTCFL distribution. Notice
the presence of GFP-CTCFL-positive cells in the upper half of the tubule and their absence in the bottom half, indicating a transient population
of cells. In (K-M) a high-magnification view of the same GFP-CTCFL-positive cells is shown. Notice the non-homogenous distribution of
GFP-CTCFL in the nucleus. In (N-P) GFP-CTCF staining is shown. For clarity, some of the cell types are encircled, and their position is indicated in
the other panels using white arrowheads. Pl=preleptone spermatocyte; rs= round spermatid; pa=pachytene spermatocyte; se= Sertoli cell. Bars,
H-J: 70 μm, K-M: 10 μm, N-P: 25 μm.
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to testes from heterozygous littermates (Figure 3A). In
addition, we found that lower testes weights coincided with
infertile males (Figure 3A). The weight distribution showsthat there are also normal testes in the Ctcfldel/del popula-
tion. Still, on average, the epididymides from homozygous
Ctcfl del mice contained only 15% of sperm compared to
heterozygous littermates (Figure 3B).
Figure 3 (See legend on next page.)
Table 1 Sub-fertility of CTCFL mutant mice
Genotype Ctcfl del/+ Ctcfl del/del
Number (percentage) of breedings
w/o offspring
3/60 (5%) 14/27 (51.9%)
Average number of offspring per
litter (± SD)
7.7 ± 2.6 6.4 ± 2.8
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germ cells by apoptosis and an increasing level of atrophy
that increased with age (Figure 3C, D). Mitotic spermato-
gonia, staining positive for BrdU incorporation, were still
often observed (Figure 3E), whereas SCP3, a marker for
spermatocytes, revealed severe tubule disorganization
(Figure 3F). In fact, the level of atrophy and disorganization
between individual mice and between individual
(See figure on previous page.)
Figure 3 CTCFL is important for spermatogenesis. A Testicular weight distribution. The testicular weight of Ctcfl heterozygous (Ctcfl del/+;
diamonds) and homozygous (Ctcfl del/del; circles) mice was measured and plotted as a normalized probability distribution (i.e., the surface under the
curve represents a total probability of 1). Testes of knockout mice are significantly smaller (p< 0.0005, t-test). White symbols represent infertile
males, black symbols are fertile males, and grey symbols correspond to males not tested for fertility. B Ctcfl mutant mice display reduced fertility.
Epididymal sperm count from Ctcfl heterozygous (Ctcfl del/+; black bar) and homozygous (Ctcfl del/del; grey bar) mice. Standard deviation is plotted
(p= 0.0002, n= 4). C Testis histology. In the left three panels a timed series of HE-stained testicle sections is shown (postnatal day 21, 28, 90), while
in the right hand panel an apoptosis assay (TUNEL staining) of testicle sections at day 90 is shown. Note that in CTCFL-deficient testes some
seminiferous tubules appear normal, whereas others (which can be adjacent to the normal ones) have lost most of their meiotic and
post-meiotic germ cells, leaving only mitotic spermatogonia (that stain positive for BrdU incorporation, see panel E) and Sertoli cells. Yet other
tubules contain disorganized spermatocytes, and some of them even elongated sperm. Thus, there is no absolute block in differentiation or
progression of germ cell development, but the incomplete penetrance of the infertility phenotype is however directly linked to the testicle
weight (panel A) and to the degenerative level of the seminiferous tubules. D Apoptosis plot. Number of TUNEL-positive apoptotic cells per 100
seminiferous tubules counted at day 28 and day 90. Standard deviation of three animals per genotype and time point is indicated. E DNA
synthesis marked by a 1-h pulse of BrdU in day 40 testicles reveals that mitotic spermatogonia are still present in degenerated tubules.
Counterstaining with hematoxylin. F SCP3 staining in spermatocytes of day 90 testicles as a marker for tubule organization. G PRSS50 co-localizes
only partially with STRA8. Immunofluorescence staining with a STRA8 antibody (top panel) or PRSS50 antibody (bottom panel) of adult testicle
sections shows that PRSS50 and STRA8 expression overlaps only partially. Scale bars are 50 μm.
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seminiferous tubules could even be adjacent to abnormal
ones. Thus, the penetrance of the atrophic testes and steril-
ity phenotype in CTCFL deficiency is incomplete and dif-
fers considerably per mouse.
Next we performed a microarray analysis on day 23
testis mRNA (a time point that precedes the start of apop-
tosis and degeneration in the testes of CTCFL-deficient
mice) on Ctcfldel/del and Ctcfldel/+ littermates. This
revealed several affected genes in Ctcfldel/del testes
(Figure 4A). The Prss50 and Gal3st1 genes were most
downregulated (~1.5 fold), which matches results from
another study [26]. Real-time RT-PCR verified results
from the microarray (Figure 4B).
GAL3ST1 is crucial for spermatogenesis as mutant mice
are infertile because of an arrest at the end of the meiotic
prophase [35]. PRSS50 (Testis Specific Protease) has an
exclusively testicular expression pattern, and is detected
both in CTCFL-positive cells as well as in later stages of
spermatogenesis [36], including STRA8/CTCFL-negative
pachytene spermatocytes (Figure 3G). Since a CTCFL-
deficiency affects differentiation of cells subsequent to the
preleptotene stage, the reduction in Prss50 and Gal3st1
mRNA may be the result of a reduction in the number of
cells going through meiosis or a reduction in Prss50 and
Gal3st1 mRNA per cell. We therefore investigated PRSS50
expression in sections of wild-type and CTCFL-mutant
mice and noted reduced protein levels per cell
(Figure 4C).
CTCFL regulates testis-specific gene expression
The whole genome DNA-binding profile for CTCF has
been elucidated in several cell systems (see, for example,
[6-9]). We sought to compare the DNA-binding profiles
for CTCF and CTCFL in the same cell type. Since CTCF
is ubiquitously expressed in the testis, whereas the pres-
ence of CTCFL is highly restricted, genome-wide DNA-binding patterns derived from whole or partially purified
testis preparations cannot be compared (see Discussion).
We therefore generated ES cells, a cell type closely related
to germ cells [37-40], in which expression of a V5- and
GFP-tagged CTCFL protein could be induced (Figure 5A),
thereby mimicking the CTCFL-positive germ cells that ex-
press both CTCFL and CTCF. Advantages of this system
are furthermore the unlimited source of cells and the pos-
sibility to sort for GFP-positive cells that express the fu-
sion protein to obtain a pure population of cells. In
addition, the V5 tag permits stringent and exclusive
immunoprecipitation of CTCFL. Thus, with this system
genome-wide RNA (micro-arrays) and DNA-binding
studies (ChIP-Seq) were carried out (Figures 5B).
Comparison of the expression of all genes on the
microarray to expression of genes bound by CTCF or
CTCFL revealed that the CTCFL-bound genes were, on
average, more abundantly expressed (Figure 5C). The
same held true when CTCFL-bound genes were com-
pared to random gene sets (not shown). These data indi-
cate that CTCFL associates with active genes. Several
genes upregulated in CTCFL-GFP-V5-induced ES cells
were also detected in the list of genes downregulated in
CTCFL-deficient testes. Real-time RT-PCR confirmed
that Gal3st1, Prss50 and even Stra8 expression were
upregulated in CTCFL-induced ES cells (Figure 5D).
Thus, CTCFL can act on male-specific germ cell genes
in ES cells, and two of the most downregulated genes in
CTCFL-deficient testis are upregulated in CTCFL-GFP-
V5-expressing ES cells. These data underscore the no-
tion that ES cells resemble germ cells and indicate that
CTCFL acts as a male germ cell gene regulator.
Genome-wide binding of CTCFL and CTCF
To determine the genome-wide binding pattern of
CTCFL, we used GFP-sorted CTCFLV5-GFP-induced ES
cells, which express both CTCFL and CTCF. The V5
Figure 4 Regulation of testis-specific genes by CTCFL. A
Heatmap representation of microarray data. We compared five
samples from heterozygous and three samples from homozygous
Ctcfl knockout mice. Depicted are the top 27 deregulated genes,
where the log2-transformed fold change compared to the average
expression in heterozygous testis is shown. B Expression analyses in
Ctcfl mutant testes. Real-time RTPCR expression analyses on testis
RNA from Ctcfl mutant mice relative to wild type using Ccna1 as
reference. Genes were examined in 90-day-old testes. C Reduced
PRSS50 expression in Ctcfl mutant testis. Immunofluorescence
analysis of testis sections from heterozygous (del/+) and
homozygous (del/del) Ctcfl knockout mice, using antibodies against
PRSS50.
Table 2 Top ten CTCFL-binding sites in induced ES cells
Chr Position Gene CTCFL bound* CTCF bound
1 6 34,872,000 Stra8 134 Yes
2 9 110,760,000 Tsp50 113 Yes
3 14 103,450,500 Irg1 105 Yes
4 9 106,114,000 Twf2 101 Yes
5 9 50,260,500 - 100 Yes
6 5 125,061,000 Tctn2 97 Yes
7 8 107,058,500 Nae1 95 Yes
8 2 29,475,000 Rapgef1 94 Yes
9 9 108,838,500 Uqcrc1 93 Yes
10 12 112,970,500 Bag5 92 Yes
*Sites are ranked based on the number of ChIP-sequence reads, filtered for
duplicates.
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ES cells as control. Normal ES cells and a rabbit poly-
clonal antibody to CTCF [4] were used for ChIP-
sequencing of CTCF. ChIP- sequencing revealed 5707
CTCFL and 37691 CTCF-binding sites (Figure 5E). To
validate our data, we compared the number and position
of CTCF sites determined by us with published data from
the same cell type [7] and found a very high overlap
(Figure 5F). Sorting the CTCFL-binding sites on the num-
ber of unique sequence reads yielded a list of genes that
was headed by Stra8 and Prss50 (Table 2), two genes that
are upregulated in CTCFL-inducible ES cells. Thus, the
most prominent CTCFL sites locate at genes that are im-
portant for germ cells.
Interestingly, only 64% (3677) of CTCFL sites overlap
with those of CTCF; conversely, only ~10% of CTCF sites
are bound by CTCFL (Figure 5E). Despite their partial over-
lap, CTCFL and CTCF bind almost identical consensussequences (Figure 5G). The most notable differences in the
DNA-binding motif are the lower prevalence of a C at posi-
tions 1 and 2, the absence of A at position 3 and a lower
prevalence for A at position 6, as well as a higher preva-
lence of G at positions 8 and 11, for the CTCFL motif rela-
tive to the one of CTCF. Whether subtle motif differences
relate to differences in numbers of binding sites or to
effects mediated through CTCFL and/or CTCF are ques-
tions currently under investigation. We also noted that,
similar to CTCF [6,9,41], not all binding sites for CTCFL
contain a consensus motif (Figure 5F).Nucleosome occupancy specifies binding of CTCFL versus
CTCF
Further analysis of the genome-wide binding of CTCF(L)
revealed that CTCFL binds almost exclusively to CTCF
consensus sites near promoter areas, in contrast to CTCF
(Figure 6A, B). We next split CTCF(L)-binding sites into
three groups, i.e., CTCFL-only sites, CTCFL+CTCF sites
and CTCF-only sites, and compared CTCF(L) binding to
published data sets of transcription factors and other
chromatin constituents. Binding sites are shown as heat-
maps, which represent individual ChIP-Seq profiles from -
2 kb to +2 kb relative to the center (peak maximum) of
the analyzed peaks (Figure 6C) and as cumulative profiles
(Figure 6D, E), which represent average ChIP-Seq profiles.
Sites were sorted for binding strength within the three
subsets. This comparative analysis revealed, for example,
that CTCFL colocalizes with cohesin at CTCF consensus
sites that are not occupied by CTCF (Figure 6C, D). In
addition, CTCFL is enriched at transcriptionally active
promoters, which are marked by H3K4me3 and PolII
phosphorylation on serine 5 (Figure 6C, D). By contrast,
CTCF-only sites are not associated with these marks.
These data confirm the observation that CTCFL associ-
ates with transcriptionally active genes (see Figure 5C).
Figure 5 Genome-wide analysis of CTCFL expression in ES cells. A Inducible expression of CTCFL-V5-GFP in ES cells. Notice the nuclear
localization of CTCFL-V5-GFP in cells expressing the protein. B Flow chart of experiments. ES cells with a Tet-on inducible expression of a
CTCFLV5-GFP transgene were sorted for GFP and used for microarray and ChIP-Seq analyses. C CTCFL expression and DNA binding are associated
with elevated gene expression levels. We plotted gene expression levels, as determined by microarray analysis of induced (ind) or non-induced ES
cells, for all genes (all), or those bound by CTCF, or CTCFL, to the respective promoter region (−2 k to +1 kb around TSS). Differences are highly
significant (p-value CTCF-ind versus CTCFL-ind: 5.1 × e-14; p-value CTCF versus CTCFL: 5.9 × e-13). D Transcript analyses in ES cells expressing
CTCFL-V5-GFP. Real-time RT-PCR expression analyses of CTCFL-V5-GFP-induced and GFP-sorted ES cells, relative to non-induced ES cells, for
the indicated genes, referenced to Cdk2 expression. E Venn diagram of DNA-binding sites for CTCFL and CTCF. F Clustered heatmap
representation of three classes of CTCF/CTCFL-binding sites. Shown are the binding profiles of CTCFL and CTCF (1: our own data; 2: [7]) across
all CTCF/CTCFL-binding sites identified in mES cells. Sites are grouped into CTCFL-only, CTCF-only, and combined CTCFL and CTCF sites.
Within the three classes, data sets were sorted decreasingly from top to bottom for average binding across the interval from 2 kb to +2 kb
around the identified binding peak center positions. Additionally the occurrences of predicted CTCFL motifs within these intervals are plotted.
G Motif comparison of CTCF and CTCFL. DNA-binding motif for CTCFL-only (top panel), CTCF + CTCFL (middle panel) and CTCF-only binding
sites (bottom panel).
Sleutels et al. Epigenetics & Chromatin 2012, 5:8 Page 9 of 21
http://www.epigeneticsandchromatin.com/content/5/1/8
Figure 6 Characterization of CTCFL and CTCF binding. A A large fraction of CTCFL-binding sites is located close to promoters. We
determined for each CTCFL-only-binding site the distance to the nearest transcriptional start site (TSS) and plotted the frequencies of binding
sites in the depicted window from −40 kb to +40 kb around the center of CTCFL-binding sites. CTCF is plotted as comparison. B Comparison of
the genomic distribution of CTCF- and CTCFL-binding sites. Sites are separated into CTCF-only, CTCFL-only and (CTCF+ CTCF). The entire genome
is also plotted (all). The binding location is separated into exon, intron, intergenic, transcription start site (TSS) and transcriptional end sites (TES),
and plotted as frequencies of total (Y ax). C Clustered heatmap representation of the three different classes of CTCF/CTCFL-binding sites with
respect to chromatin context. We compared CTCF and CTCFL binding to published ChIP-sequencing data sets for the cohesin complex subunit
Smc1, H3K4me3, a phosphorylated form (serine 5) of RNA PolII, (PolIISer5P) and histone H3 [8,42,43]. D Cumulative profiles across the three
different classes of CTCF/CTCFL-binding sites with respect to chromatin context. The average ChIP-sequencing profiles are shown for the same
data sets as in (C). E Cumulative profiles across the three different classes of CTCF/CTCFL-binding sites with respect to H3.3.
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tone H3 we noted that CTCFL preferentially binds large
H3-depleted areas (Figure 6C, D). By contrast, CTCF is
enriched on sites that display H3 phasing around the
CTCF-binding site (Figure 6D). These sites, in turn, do
not attract CTCFL. Shared CTCFL/CTCF sites associate
with “intermediate” H3-free regions (Figure 6C, D). As the
H3-binding site analysis was performed in ES cells that do
not express CTCFL, we conclude that the H3 depletion inthese cells is not caused by CTCFL, but that H3-depleted
regions appear to attract CTCFL.
It has been observed that many “H3-free” regions in
the genome in actual fact do contain histones, but that
these are loosely assembled and are lost upon DNA ex-
traction with high salt [44]. The variant histone H3.3 has
been shown to occupy these areas, often together with
another variant histone, H2A.Z [45]. We therefore com-
pared CTCFL binding to that of H3.3 (for which data
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these two proteins colocalize (Figure 6E), whereas CTCF
does not associate with H3.3-enriched regions. We con-
clude that in addition to nucleotide sequence, nucleo-
some occupancy and composition specify the genome-
wide binding of CTCFL and, surprisingly, of CTCF.
Competition between CTCFL and CTCF on distinct sites
ChIP-sequencing and direct ChIP experiments showed
that CTCF and CTCFL bind the same site within the
Stra8 and Prss50 promoters, but not in the Gal3st1 pro-
moter (Figure 7A). We therefore tested the idea that
these two proteins compete for binding on selected sites.
Using in vitro band shift assays, we confirmed that
CTCFL and CTCF bind the Stra8 and Prss50 promoters
(Figure 7B, C). When proteins were added together we
did not observe a higher band, indicating that CTCF and
CTCFL do not interact to bind a probe simultaneously
(Figure 7C). Instead, with increasing amounts of CTCFL,
the amount of bound CTCF diminished (Figure 7C),
suggesting that CTCFL and CTCF compete for binding
sites in vitro.
To examine whether competition occurs in vivo, we used
ChIP analysis on CTCFL-induced and -non-induced ES
cells using a selected number of sites. In the presence of
CTCFL, the amount of bound CTCF was reduced for both
Stra8 and Prss50 (Figure 7D). CTCFL induction had no ef-
fect on CTCF in the CTCF-only-binding site within the
Chr10 locus (Figure 7D). However, for the shared CTCFL/
CTCF-binding site at Vps18 we also saw no effect on CTCF
binding (Figure 7D). These ChIP results indicate that
CTCFL can compete with CTCF, but only at specific sites.
To test this hypothesis on a genome-wide level, we transi-
ently transfected GFP-CTCFL into ES cells and examined
differences in CTCF binding in ES cells expressing GFP-
CTCFL compared to cells not expressing this protein. As
shown in Figure 7E (left panel), in the presence of CTCFL,
binding of CTCF was reduced on ~1,100 sites, whereas
binding on ~100 sites was increased. Binding of CTCF to
the affected sites was significantly reduced as compared to
all CTCF-binding sites (Figure 7E, right panel). Among sites
displaying reduced CTCF binding were the Prss50 and
Stra8 promoters, but not Vps18 and chromosome 10 bind-
ing sites (not shown). These results are consistent with the
ChIP data (Figure 7D). We conclude that in ES cells,
CTCFL and CTCF compete on distinct sites.
To estimate the physiological relevance of our genome-
wide ES cell data we performed ChIP using antibodies
against CTCFL and CTCF on selected sites in cells isolated
from wild-type testis by elutriation. Results show preferen-
tial binding of CTCFL to the Stra8 and Prss50 promoters,
and preferential binding of CTCF to Vps18 (Figure 7F), in-
dicating that the differential binding pattern of CTCF and
CTCFL observed in ES cells is present in testis as well.CTCFL is functionally different from CTCF
The co-expression of CTCFL and CTCF in late sperm-
atogonia and preleptotene spermatocytes combined with
their differential genome-wide binding patterns raises
the question whether CTCFL and CTCF are functionally
redundant, complementary or antagonistic. To test
whether CTCFL can functionally substitute for CTCF,
we designed an ES cell rescue assay (Figure 8A). ES cell
lines were derived from mice carrying the conditional
Ctcf knockout allele (Ctcf lox/lox [4]). Ctcf is deleted upon
lentivirus-mediated Cre recombination, and these cells
fail to form colonies because CTCF-deficient cells
(Ctcfdel/del) do not survive. A rescue of cell death by
concurrent introduction of CTCFL would show that the
two proteins compensate for each other.
Using this strategy we co-expressed Cre with GFP-tagged
mouse CTCF, YFP-tagged chicken CTCF or GFP-tagged
mouse CTCFL in Ctcflox/lox ES cells (Figure 8A). Resulting
colonies were analyzed on the DNA level for Cre-mediated
CTCF deletion of Ctcf lox/lox into Ctcfdel/del (Figure 8B) and
on the protein level for expression of endogenous or ex-
ogenous protein (Figure 8C). A few surviving colonies
transduced with Cre-only were observed (Table 3), but
these had not performed the Cre-mediated CTCF deletion
completely and thus still expressed endogenous CTCF
(Figure 8B, C). However, nearly all colonies transduced with
N- or C-terminally tagged mouse CTCF, or with C-
terminally tagged chicken CTCF, had deleted endogenous
Ctcf lox/lox, and expressed fluorescently tagged exogenously
introduced protein (Figure 8B, C, Table 3). Thus GFP-
tagged mouse CTCF and even chicken CTCF, which is 96%
identical at the amino acid level to mouse, can functionally
substitute for endogenous CTCF.
Strikingly, rescue experiments with GFP-tagged mouse
CTCFL yielded no ES cells in which both endogenous
Ctcflox/lox alleles were deleted and wild-type protein was
replaced (Figure 8B, C, Table 3). These data indicate that ei-
ther CTCFL and CTCF are not interchangeable or that
GFP-CTCFL is not a functional protein. To demonstrate
that GFP-CTCFL is functional, we transiently transfected
the protein into ES cells and examined DNA binding of
GFP-CTCFL on selected sites and the induction of expres-
sion of testis-specific genes. ChIP experiments showed that
GFP-CTCFL binds the three selected sites (Figure 8D) and
that Gal3st1, Stra8 and Prss50 expression is induced inES
cells expressing this fusion protein (Figure 8E). These data
demonstrate that GFP-CTCFL is functional.
Discussion
We have used a combination of approaches and technolo-
gies to unravel the physiological function of the testis-
specific paralog of CTCF, called CTCFL or BORIS. We find
that CTCFL is only expressed in late spermatogonia and
preleptotene spermatocytes, and that CTCFL-deficient mice
Figure 7 Characterization of CTCF and CTCFL binding. A Examples of CTCF- and CTCFL-binding site location. The genomic location of CTCF
(upper part) and CTCFL (middle and bottom parts) binding sites in the absence (−CTCFL, middle) or presence (+CTCFL, bottom) of CTCFL, within
the Stra8, Prss50 and Gal3st1 genes. The vertical axes show the number of unique sequence reads. B CTCFL binds to Stra8 and Prss50. Band shift
analyses of GFP-CTCFL on Stra8 and Prss50 fragments. GFP-CTCFL binding can be super shifted (marked with asterisks) with anti-GFP, but not
with an Actin antibody. Band shifts were performed under excess probe conditions. C In vitro effect of CTCFL on CTCF binding. Band shift
analyses with GFP-CTCF and/or GFP-CTCFL on Prss50- and Stra8-bindings sites. GFP-CTCFL is added in increasing amounts (1-, 2-, 5- and 10-fold
compared to GFP-CTCF). To allow competition, the band shift was performed under probe-limiting concentrations. D Cellular effect of CTCFL on
CTCF binding. ChIP analyses with CTCFL (blue), CTCF (red) and pre-immune (yellow) antisera in ES cells that were either non-transfected (−) or
transiently transfected CTCFL-V5-GFP (+). According to ChIP-sequencing data, Prss50, Stra8 and Vps18 bind both CTCF and CTCFL, whereas
Gal3st1 only binds CTCFL, and Chr10 only binds CTCF. A CTCF- and CTCFL-negative site within the Amylase gene is used as reference and set to
1. Error bars represent standard deviations of biological replicates. E Competition between CTCF and CTCFL in ES cells. Genome-wide binding of
CTCF was compared to that of CTCFL by ChIP-Seq using non-transfected ES cells and ES cells transiently transfected with GFP-CTCFL. The left
hand panel shows the effect of CTCFL binding on shared CTCFL/CTCF sites that showed >1.5 fold difference in CTCF binding. The effect is
categorized into sites with increased (up) or decreased (down) CTCF binding. The right hand panel shows a more general effect of CTCFL binding
on CTCF binding. Here, we examined the change in CTCF binding in all shared CTCF(L)-binding sites (all) compared to those shared sites that
were significantly changed in CTCF binding (changed). The effect on CTCF binding is plotted as log2-fold difference. F In vivo CTCF(L) binding.
ChIP was performed using anti-CTCF (red) or anti-CTCFL (blue) antibodies, or pre-immune serum, on the indicated sites (A: Amylase, S: Stra8, P:
Prss50, V: Vps18) in nuclei from dissociated seminiferous tubules, partly purified by elutriation. Relative enrichment is shown compared to
Amylase.
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Figure 8 CTCFL is functionally different from CTCF A Strategy for the rescue of CTCF-depleted ES cells. Ctcf lox/lox ES cells were infected with
lentivirus containing the Cre recombinase and/or fluorescently tagged CTCF(L) proteins. After infection neomycin-resistant colonies were picked
and analyzed. m=mouse, g= chicken. B Analysis of Ctcf lox/lox deletion. After infection with CRE-containing constructs, Ctcf lox/lox ES cells were
scored for the status of the conditional Ctcf alleles by DNA blot. The position of wild-type (wt), deleted (Ctcf del, or del) and conditional (Ctcf lox, or
lox) loci in control ES cells (C), non-treated Ctcf lox/lox ES cells (1) and lentivirally transduced Ctcf lox/lox ES cells (2–5, see panel A for numbering of
constructs) is indicated. Cells are considered rescued when both conditional CTCF alleles have been deleted. C Analysis of CTCF protein
expression. Neomycin-resistant colonies were grown and analyzed by Western blot for CTCF (upper panel) or GFP (lower panel) expression. Note
that rescued cells are negative for endogenous CTCF. D, E GFP-CTCFL is a functional protein. ES cells were transiently transfected and harvested
after 1 day. ChIP (DNA, D) and RT-PCR (mRNA, E) analyses revealed that GFP-CTCFL binds Vps18, Stra8 and Prss50 promoters (D) and is able to
induce expression of Gal3st1, Stra8 and Prss50 (E).
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functionally different proteins. CTCFL therefore has a
unique role in the adult testis. It has been proposed that
CTCFL is involved in genomic imprinting of the Igf2-H19
locus and other sites [19,24]. However, imprint-related
mutations often have embryonic phenotypes [25]. We did
not observe this in Ctcfldel/del mice, and despite their
reduced fertility Ctcfldel/del mice could be bred through
multiple generations. Furthermore, we have not been ableto detect DNA methylation aberrations in specific loci in
Ctcfldel/del mutant mice and in CTCFL-over-expressing cells
(data not shown). This makes a role for CTCFL in DNA
methylation-dependent genomic imprinting unlikely. The
combined microarray data from CTCFL-deficient testis and
CTCFL-expressing ES cells, and the preference of CTCFL
for promoters instead suggest a function as a transcriptional
regulator, required for the proper expression of a subset of
male germ cell genes.
Table 3 Rescue of CTCF-deficient ES cells by exogenously
introduced GFP-CTCF(L)
Species Construct Deletion
in ES
cells**
Partial
deletion in
ES cells**
No deletion
in ES
cells**
Functional
CTCF
substitution
N.a.* GFP-CRE 0% (0/65) 28% (18/65) 72% (47/65) No
Mouse GFPCTCFL- 0% (0/18) 50% (9/18) 50% (9/18) No
Mouse CTCFGFP-
CRE
83% (19/23) 0% (0/23) 17% (4/23) Yes
Mouse GFPCTCF-
CRE
95% (40/42) 2% (1/42) 2% (1/42) Yes
Chicken CTCFYFP-
CRE
90% (37/41) 2% (1/41) 7% (3/41) Yes
*: Not applicable.
**: Percentage and number of clones (between brackets) in which the
conditional CTCF alleles were deleted, partially deleted or not deleted are
shown.
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are on the promoters of the testis-specific Stra8 and
Prss50 genes. The expression of these genes, and of
Gal3st1, is upregulated in ES cells expressing CTCFL.
Conversely, expression of Prss50 and Gal3st1 is downre-
gulated in germ cells lacking CTCFL, at all ages exam-
ined, whereas Stra8 expression is affected at some but
not all ages (data not shown). We speculate that the
combined transcriptional deregulation of genes causes
the testicular degeneration and reduction in fertility in
Ctcfl knockout mice. Note that the expression of these
genes is not completely hampered, which explains why
the testicular phenotype in the knockouts is milder than
the fully sterile phenotype described, for example, for
STRA8- and GAL3ST1-deficient mice [29,30,35].
The phenotype of the Ctcfldel/del mice reported here only
partly matches a recent report on another strain of CTCFL-
deficient mice, in which exons 1 to 8 of Ctcfl were also
deleted [26]. For example, the effect of a Ctcfl deletion on
the average testicular size and on Gal3st1 and Prss50 ex-
pression is similar. However, our analysis also reveals a re-
duction in fertility in the Ctcfldel/del mice not noted
previously [26]. In addition, the fact that some Ctcfldel/del
mice have normal testis size and others have a combination
of normal and abnormal seminiferous tubules was also not
described. This is relevant, as this incomplete penetrance of
the Ctcfl phenotype, even within a single testis, suggests
that a stochastic mechanism determines whether CTCFL-
deficient tubules degenerate or not. Finally, CTCFL was
proposed to be present in round spermatids and to function
during meiosis based on mRNA expression data [26]. By
contrast, our data show that CTCFL is expressed earlier,
just prior to the onset of meiosis, and we conclude that
CTCFL protein expression precedes the developmental
germ cell stages that show the major phenotypes in Ctcfl
knockout mice. We propose that in the absence of CTCFL,
epigenetic marks controlled by this protein gradually breakdown in a stochastic manner. Spermatogonia and primary
spermatocytes exist in syncitia, in which each cell is con-
nected with the other cells at the same step of development
via intercellular bridges. Only in syncytia where the expres-
sion of CTCFL-controlled genes has been affected beyond a
specific threshold will degeneration become apparent.
Neither CTCFL nor CTCF is saturating all consensus-
binding sites present in the genome, and thus the DNA se-
quence is not the sole determinant of CTCF(L) binding.
DNA methylation and hydroxymethylation are not a de-
cisive aspect, as comparisons of DNA (hydroxy)methylation
data sets to our CTCF(L)-binding sites does not provide an
explanation for why CTCFL and CTCF occupy different
binding sites (data not shown) [47]. Instead, the data sug-
gest that binding of CTCFL and of the “master weaver”
CTCF is specified by nucleosome occupancy and compos-
ition. We find that CTCFL prefers CTCF consensus sites in
promoters that are embedded in regions that appear to be
nucleosome-free. By contrast, CTCF is enriched on distinct
sites, which are devoid of histone H3 on the binding site it-
self, but which are surrounded by ordered, or “phased,”
nucleosomes. This preference of CTCF has already been
described [11-13].
It has recently been shown that unstable nucleosomes are
lost when histones are prepared with conventional condi-
tions; thus, regions containing these histones appear as
nucleosome-free in the analysis, but are in reality not free
[45]. Nucleosomes containing the variant histone H3.3 are
quite unstable, and those containing both H3.3 and H2A.Z
even less [44]. Since we find a correlation between CTCFL
binding and H3.3 occupancy in ES cells, H3.3 and H3.3/
H2A.Z might be determinant factors able to attract CTCFL
and evict CTCF. It is important to realize that in ES cells
H3.3-enriched genomic regions do not require CTCFL to
be set up, yet the protein prefers such areas after its induc-
tion. A similar situation may exist in testis, i.e., specific
H3.3/H2A.Z-containing regions might be set up during
early phases of spermatogenesis; upon its expression,
CTCFL “lands” on these regions, possibly evicting CTCF
from some promoters. Notably, during male meiosis, and
thus subsequent to CTCFL expression, H3.3 is incorporated
into unsynapsed chromatin, which is transcriptionally in-
active [48]. The function of CTCFL might be to ensure the
expression status of genes by distinguishing specific
promoter-associated H3.3 domains from whole chromo-
some domains that also contain H3.3. Through its inter-
action with SET1A [49], CTCFL might enhance H3K4
trimethylation at a subset of its binding sites.
The cohesin complex has a role in chromosome segre-
gation, DNA-damage repair and gene regulation [50].
Although cohesin does not have a typical DNA-binding
motif, it was shown to bind primarily to CTCF consen-
sus sites [16,17,51]. Moreover, the SA2 subunit of cohe-
sin directly interacts with the C-terminus of CTCF [52].
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to that of CTCF. Recent studies revealed that also in ES
cells cohesin binding largely overlaps with that of CTCF;
however, there are ~2,000 cohesin sites with a CTCF
motif that do not bind CTCF, while ~270 other cohesin
sites do not have a CTCF consensus site [10]. Our data
suggest that CTCFL binds these ~2,000 cohesin sites in
CTCFL-GFP-V5-expressing ES cells.
However, in normal ES cells CTCFL is not expressed,
raising the questions how a specific nucleosome com-
position and occupancy can be built around CTCF con-
sensus sites that appear not to be occupied by CTCF,
and how cohesin can stably bind these very same sites.
We hypothesize that these sites might be bound by a
modified form of CTCF, such as poly(ADP-ribosyl)ated
CTCF [53]. This protein would not be able to bind DNA
tightly and could be replaced very efficiently by CTCFL.
Perhaps another molecular function of CTCFL in the
testes is to interfere with and/or change the dynamics of
CTCF and cohesin-mediated chromatin looping.
We observed competition between CTCF and CTCFL in
ES cells, but only on a small subset of all CTCF-binding
sites. Nucleosome occupancy and composition, CTCF(L)
expression levels and posttranslational modifications on
CTCF(L) could all determine whether competition between
the proteins occurs on a given site. Our data reveal that
CTCF and CTCFL co-localize within the nuclei of late
spermatogonia and preleptotene spermatocytes, and the
proteins might therefore also compete in vivo. ChIP experi-
ments in testis extracts indeed reveal preferential binding of
CTCFL at the Stra8 and Prss50 promoters and exclusive
binding of CTCF to the Vps18 site. These data are consist-
ent with binding profiles in ES cells. If competition on the
Stra8 and Prss50 genes does occur in vivo, then CTCFL
could be a gene activator by preventing the binding of
CTCF. In Ctcfl knockout mice binding of CTCF to these
genes might actually diminish their expression. However,
CTCF is ubiquitously expressed in the testis, whereas
CTCFL is only transiently present in spermatogonia and
preleptotene germ cells. One would expect to see significant
binding of CTCF to the Stra8 and Prss50 sites in the tes-
ticular extracts that we used, since most cells in these
extracts contain CTCF and not CTCFL. The questions why
CTCF is not highly enriched on the Stra8 and Prss50 pro-
moters in testis, and whether these proteins compete
in vivo can only be answered once there are tools available
to isolate CTCFL-positive and -negative cell populations
from testis so that genome-wide analyses can be performed
on purified testicular fractions.
In human germ cell tumors, CTCFL is specifically upre-
gulated in spermatocytic seminomas, which are benign
testicular tumors originating from a spermatogonium or
primary spermatocyte [54]. This fits with our observed
cellular localization of CTCFL and could potentially pointto an oncogenic role for CTCFL in these tumors. In fact,
CTCFL belongs to the group of cancer testis antigens
(CTAs), genes that are normally expressed in testis yet ab-
errantly expressed in a variety of cancers. One model
holds that competition between CTCF and CTCFL plays a
role in tumorigenesis, i.e., aberrant CTCFL expression
would displace CTCF, and affect DNA methylation and
the expression of other CTAs, including the NY-ESO-1
and MAGE-A1 genes [22,23], and even other important
genes, such as the TERT gene, which encodes telomerase
[55]. However, while there might be a relationship be-
tween DNA demethylation and the expression of CTAs
[56], recent reports have shown that expression of CTCFL
alone is not sufficient to induce expression of CTAs
[27,57]. Furthermore, our data in CTCFL- deficient testis
indicate that, if anything, CTCFL represses the Tert gene
instead of activating it. To address a potential role of
CTCFL in cancer, a correlation analysis of CTCFL bind-
ing, nucleosome occupancy and composition, and CTA
expression in different types of cancers might be more
revealing.
Conclusions
The three-dimensional folding of the eukaryotic genome
serves to compact DNA while allowing gene expression.
CTCF has been termed the “master weaver” of the gen-
ome, since this protein is a key coordinator of chromatin
loop formation. In this study we have analyzed the physio-
logical function and DNA-binding profile of CTCFL, a
protein that is highly similar to CTCF but that is only
expressed in the male germ line. Using a combination of
cell biological, biochemical and bioinformatics approaches,
we show that CTCF and CTCFL are functionally different
proteins that bind to similar sites in the genome, but
whose binding does not overlap completely. Our data sug-
gest that nucleosome composition specifies the genome-
wide binding of both CTCFL and CTCF. We show that
CTCFL is only transiently expressed, in spermatogonia
and preleptotene spermatocytes, prior to male meiosis.
We propose that during its expression CTCFL occupies a
subset of promoters and thereby maintains the expression
of selected male germ cell genes.
Methods
RACE PCR and RNase protection assay
Human CTCFL was shown to consist of 23 isoforms with
variations in N- and C-termini and zinc finger modules
with different DNA-binding and transcriptional character-
istics [58]. To analyze the genomic organization of the
murine Ctcfl gene, we cloned the 5’ end of the Ctcfl cDNA
by a rapid amplification of cDNA ends-polymerase chain
reaction (RACE-PCR) procedure, using first choice RACE
ready testicular cDNA from Balb/c mice (Ambion) and
nested oligos (see Table 4 for sequence). Compared to the
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derived first Ctcfl exon is smaller and lacks an upstream
ATG, and it is preceded by an intron of 489 bp and an
additional exon of 130 bp (see also panel 1C). The se-
quence of the Ctcfl 5’end product has been submitted to
Genbank (accession no.: EU154995). Our cDNA structure
matches the HAVANA/VEGA curated sequences in
Ensembl, Build 36 [59].
RNase protection assay (RPA) was performed accord-
ing to the manufacturer’s instructions (RPAII, Ambion).
For Ctcfl the RPA was performed on poly A + purified
RNA with probes spanning Ctcfl exons 8 and 9 (pro-
tecting 146 bp), spanning bp 1–220 of the Ctcfl race
PCR product (up to oligo 3, see figure S1C) or, alterna-
tively, spanning bp131-220 (protecting 89 bp), to detect
the existence of another start site [19]. For Ctcf the
RPA was performed on total RNA with a probe protect-
ing 99 bp of Ctcf exon 2. The RPA with the 5’end
RACE confirms that Ctcfl mRNA mRNA contains the
additional upstream exon as identified by the RACE
PCR. We found no evidence for alternative splicing in
murine Ctcfl.Mouse models
To generate the Ctcfl and Ctcf knockin alleles we inserted a
Gfp-encoding cDNA, followed by a Loxp-flanked neomycin
selection cassette, in the Ctcfl and Ctcf exons, respectively,
that contain the ATG start codons. Insertion of GFP imme-
diately downstream of the translational start sites yielded
Ctcflgfp-neo and Ctcfgfp-neo ES cells. Homology arms were
generated by cloning from the RPCI21 129 PAC library
(Geneservice). Constructs were sequenced, electroporated
into isogenic ES cells (129/IB10) and neomycin- (or, later
on, puromycin-) selected, analyzed by Southern blot and
PCR, and injected into C57/Bl6 blastocysts.
Mice generated from Ctcfl gfp-neo and Ctcfgfp-neo ES cells
were crossed to transgenic mice expressing Cre to delete
the LoxP-flanked neomycin cassette. This yielded Ctcfl gfp
mice in which the GFP is fused in frame to CTCFL and
Ctcfgfp mice where GFP is fused to CTCF. These mice are
phenotypically normal and fertile (data not shown).
The Ctcfl gfp-neo ES cells were retargeted with a LoxP-
flanked puromycin cassette downstream of exon 8. Mice
were generated using the Ctcfl gfp-neo-puro ES cells. The
Ctcfldel mice were subsequently generated by crossing
Ctcfl gfp-neo-puro mice to Cre-expressing mice. This resulted
in the in vivo deletion of Ctcfl exons 1–8 and both selec-
tion cassettes as these were in between the LoxP sites.
Mice were maintained on a C57/Bl6 background at the
Erasmus MC animal care facility under specific pathogen-
free conditions. Animal experiments were reviewed and
approved by the Erasmus University committee of animal
experiments.Cell culture, transfection and infection
The Ctcflox/lox ES cells were isolated de novo from CTCF
conditional mice [4] and grown on plastic in the pres-
ence of LIF. Lentiviral constructs were generated with
Ctcf and Ctcfl cDNAs driven from a CAG promoter
(CMV early enhancer/chicken β actin), followed by an
IRES sequence and the Cre recombinase. Expression of
a neomycin selection cassette was driven by a PGK pro-
moter. Lentivirus particles were produced as described
(Addgene). ES cells were infected in suspension for 4 h,
plated and selected with G418 the next day. Clones were
analyzed by Southern blot for the status of the Ctcflox/lox
conditional allele [4] and by Western blot using GFP
(Abcam 32146) or CTCF antibody (BD Bioscience).
For the inducible CTCFL expressing ES cells, ROSA26-
rtTA ES cells were Lipofectamine transfected (Invitrogen)
with a TRE-mCTCFL-V5-GFP-neomycin construct and
selected with G418. Clones were analyzed for the induc-
tion and expression of CTCFL-V5-GFP by flow cytometry
for GFP (FACSAria, BD Biosciences), and by Western blot
and immunofluorescence using rat monoclonal anti-
CTCFL antibodies raised against mouse CTCFL (AA 1–
113 and AA 569–635) and V5 antibody (Sigma, V8012).
Transient transfections of mCTCFL-V5-GFP and of GFP-
mCTCFL in ES cells were done with Lipofectamine 2000
(Invitrogen).
Chromatin immunoprecipitation (ChIP)
\ChIP was performed as described [14] or according to
the Magnify system procedure (Invitrogen). Briefly, prep-
aration of cross-linked chromatin (2× 107 cells treated
with 1% formaldehyde for 10 min at room temperature),
sonication of chromatin to yield fragments up to 800 bp,
and immunoprecipitation with V5-Agarose beads (Sigma,
A7345) or with polyclonal CTCF(L) antibodies [4] were
performed as described in the Upstate protocol (http://
www.upstate.com). Ct values from real-time PCR were
normalized to input measurements, and enrichment was
calculated relative to the Amylase gene. For oligos used,
see Table 4. ChIP was performed on nuclei derived from
induced or transiently transfected ES cells (see above) or
from seminiferous tubules in which multiple testicular cell
populations were first dissociated by enzymatic digestion
of seminiferous tubules and subsequently isolated by
elutriation.
ChIP-sequencing and analysis
For ChIP-sequencing a DNA library was prepared from
the ChIPped DNA according to the Illumina protocol
(www.illumina.com). Briefly, 10 ng of end-repaired DNA
was ligated to adapters, size selected on gel (200 ± 25-bp
range) and PCR amplified using Phusion polymerase as
follows: 30 s at 98 °C, 18 cycles of (10 s at 98 °C, 30 s at
65 °C, 30 s at 72 °C) and 5 min at 72 °C final extension.
Table 4 Oligos
Oligos used for RACE PCR
Name Forward Backward
RACE GGACACTCGTATTTGGGCACATTC CACAGGGAGCACTTGAAGGGCTTC
Oligos used in real-time PCR for ChIP
Name Forward Backward
Gal3st1 TCCTGGGTGAGGTCAGGAAG GGAACTCCGAGTAGCTTCAATG
Stra8 TCCTAGAGAAGGGGGTGTTACC AGCTGACCACCACACGTTTTC
Prss50 AGAGGAGGGTAGGGGTATCGAC TCGCCTCAGCTAATTTCTAAGC
Vps18 CTGCTGCAGTTCCTCATGTTG GTGTGACAGATGGAGGAGCAC
Chr10 AAGGTTGGTAGCTCTGCTTGGACTGCTCG AATGTCACAAGCAAAGAAAAGCACGCAAAT
Amylase AATTCTCCTTGTACGGCTTCGTG TAGCAATGATGTGCACAGCTGAA
Oligos used in real-time PCR for RNA expression
Name Forward Backward
Clgn TGTCTTCCTTACTCTTCTCTTCCG GAAGCCAGGTGAAGCTGAGGTC
Ctcf CCACCTGCCAAGAAGAGAAGG GCACCTGTATTCTGATCTTCGAC
Tcfl5 ACGAGATAGGAGGCGCAGAATC GTTGTTGCTTTATCTGTCTCCG
Gal3st1testis-specific form GCTACTCGGAGTTCCGGAAA GACTTGCAGGGCTTCTTTGG
Gal3st1 ACTGTATCCCAACATGGCCTTC ATATCTCGCCGAGGTTGACAC
Stra8 GGCAGTTTACTCCCAGTCTGATA CAACTTATCCAGGCTTTCTTCCT
Prss50 GACAGTTCTCTCTGCACTGTGAC CACATTTCTTGCTGTTCAGGATA
Ctcfl GCTCTGGCTGTGCACCTTACG CCCACTGTGCCACCATCATC
Ccna1 GAGTATGCAGAGGAGATTCATCG TCATGTAGTGAGCCTTGGGTCTG
lpcat2 AGCACCCAGTGAGGAAGAGA TTCGTAGGTGTGATCCGTCA
itfg3 ACGAGGTGTCTTCTGCCTGT GTTCCCACTAAAGCTGCTGG
dio2 TGCAGATCCTGCCAGTCTTT CACACTGGAATTGGGAGCAT
hgf GATGAGTGTGCCAACAGGTG GGTCAAATTCATGGCCAAAC
akr1c18 CCAGGCCATTCTAAGCAAGA TCAGGGAATTTTCCAAGCTG
Oligos used in EMSA
Name Forward Backward
Stra8 GGATCTGTGCTGTGTGTCCTCCTCGACTCCT CCTCTAGGAGTCGCAAGTGACCCACACATGCATGC
AGAGCATGCATGTGTGGGTCACTTGCGACTC
CTAGAGGA TCTAGGAGTCGAGGAGGACACACAGCACAGATCCT
Prss50 ATCTAGGGGGCGCCACGCAGGCTGGGCACC CCACAATGGCGCCCTCCATCGGGCGCCTCATGGT
AGCGCACCATGAGGCGCCCGATGGAGGGCG GCGCTGGTGCCCAGCCTGCGTGGCGCCCCCTAGATG
CCATTGTGGA
Oligos used for generating transgenic mice and cells
Name
Oligo 1 5-TCTTTTTCCATCAGGGGTCGTCAC-3
Oligo 2 5-GAGAAGCGCGATCACATGGTCCTG-3
Oligo 3 5-GCACCGTTTGCAGGGTCAGGATC-3
Oligo 4 5-TCCAAATCACAGCGCCACCTACAG-3
Oligo 5 5-GGTTCTTAGAGATAGGGTTTCTCTG-3
Oligo 6 5-GGTGTTCTGCTGGTAGTGGTC-3
Oligo 7 5-CGGCATCAGAGCAGCCGATTG-3
Oligo 8 5-GTTATGATCTGGGTATCGTCCACTG-3
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Cluster Reagents preparation, and the library was
sequenced on the Illumina Genome Analyzer IIx plat-
form to generate 36-bp reads. Images were recorded and
analyzed by the Illumina Genome Analyzer Pipeline
(GAP) and processed using the IPAR (Integrated Pri-
mary Analysis Reporting Software) and the GAP. The re-
sultant sequences were mapped against NCBI Build 37.1
of the mouse genome using the ELAND alignment soft-
ware (Illumina).
Published data sets generated for mouse ES cells were
downloaded from NCBI’s gene expression omnibus (GEO).
We used the following data sets: H3: GSM587479, CTCF:
GSM288351 [7], Smc1: GSM560341 and GSM560342 [8],
H3K4me3: GSM594581 [42], PolIIser5p: GSM515662 [43]
and H3.3-HA: GSM423355 [46]. Reads were converted to
the fastq format and aligned to a precompiled mm9 refer-
ence index with BOWTIE [60]. In case multiple sequencing
lanes were available, fastq files were merged before align-
ment. Unambiguously mapped and unique reads were kept
for subsequent generation of binding profiles and calling of
peaks using MACS with an fdr< 0.05 [61]. Downstream
analysis was done in R/BioConductor (http://www.biocon-
ductor.org), partly according to published strategies [62].
For comparative ChIP-Seq analysis mapped reads were
transformed to continuous binding profiles. Those were
used to collect data in 4-kb windows spanning CTCF and
CTCFL binding sites. The binding sites were grouped into
three classes based on intersection analysis: sites bound by
CTCF only, CTCFL only, or both CTCF and CTCFL. The
binding data were binned across binding sites in 50-bp
windows, and the mean was calculated at each position in
order to generate cumulative binding profiles. Alterna-
tively the complete data were plotted in heatmaps. The
identified CTCFL-binding motif was used to scan the
mm9 genome using the Patser tool [63] and plotted as a
heatmap after the motif data had been binned, as
explained for the binding profiles.
RNA analyses
Expression analyses by real-time PCR were performed as
follows: total RNA was isolated with RNA-Bee (Tel-Test
Inc.). RNA was reverse transcribed (RT) with a combination
of random and oligo-dT primers by Superscript reverse
transcriptase (Invitrogen), and real-time RT-PCR was per-
formed with a Sybrgreen platform on a Bio-Rad CFX
Cycler. For oligos used, see Supplemental Information.
For testis and ES cell microarray analysis, the purity
and quality of the isolated RNA were assessed by RNA
6000 Nano assay on a 2100 Bioanalyzer (Agilent Tech-
nologies). Then 5 ug testes RNA was used for the pro-
duction of cRNA. Labeled cRNA was hybridized to the
GeneChip Mouse Genome 430 2.0 array oligonucleotide
microarray (Affymetrix) according to manufacturer’srecommendations; 300 ng ES cell RNA was used for
production of end-labeled biotinylated ssDNA. Labeled
ssDNA was hybridized to the Mouse Gene 1.0ST array
(Affymetrix) according to manufacturer’s recommenda-
tions. Measured intensity values were analyzed using the
Gene Expression Console (Affymetrix) and normalized
by quantile normalization.
Scanned microarray data were processed using R/Bio-
conductor using standard procedures. Normalization and
background correction were done by RMA. Differentially
expressed genes were determined using the limma pack-
age within R [64]. For visualization the mean expression
was determined across the heterozygous samples, which
was then subtracted from the expression levels for the in-
dividual samples. For the analysis of the association be-
tween gene expression and CTCFL/CTCF binding, RefSeq
genes were downloaded from the UCSC genome browser
homepage. For each gene represented on the MoGene 1.0
ST array, the nearest CTCF or CTCFL site was calculated.
Genes with a binding site within an interval from −2 kb to
+1 kb around the transcriptional start sites were deter-
mined as bound. Log2-transformed expression values
derived from Affymetrix analysis of mES cells was then
plotted for the identified genes.
All Chip-seq and Microarray datasets are available at
NCBI Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/) under accessions: GSE34091, GSE34092,
GSE34093 and GSE34094.
Electrophoretic mobility shift analysis (EMSA) or band
shift analysis
Nuclear extracts were obtained from mock-transfected
HEK 293 T cells and HEK 293 T transfected with pEGFP,
pEGFP-mCTCF or pEGFP-mCTCFL. After 24 h, cells
were harvested, washed with cold PBS, resuspended in
buffer 1 [10 mM HEPES; 10 mM KCl; 0.25 mM EDTA
pH 8, 0.125 M EGTA-K pH 8, 0.5 mM Spermidin, 0.1%,
NP40, 1 mM DTT, protease inhibitor cocktail set I (Cal-
biochem)] and incubated for 10 min on ice. Cells were
then centrifuged 5 min at 1,500 rpm. The supernatant was
removed, and the pellet was resuspended in 50 μl of buffer
2 [20 mM HEPES; 0.4 M NaCl; 0.25 mM EDTA, 1.5 mM
MgCl2, 0.5 mM DTT, protease inhibitor cocktail set I
(Calbiochem)] and incubated 1 h at 4 °C. Samples were
centrifuged for 30 min at 15,000 rpm, and the supernatant
(nuclear extract) was frozen at −70 °C until used.
Radiolabeled probes were generated by PCR of genomic
DNA (for oligos used, see Table 4). In all cases the PCR
was performed in a final volume of 50 μl containing 3 μl
of [α-32P]dCTP (Hartman Analytic), 20 ng of genomic
DNA (from K562 cells), 0.2 mM each dNTP, 0.5 μM of
each primer and 1U of DFS-Taq DNA polymerase
(BIORON). The PCR fragments were purified using the
Wizard SV Gel and PCR CleanUp System (Promega).
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the nuclear extract with 6 μl of EMSA buffer (1.5 μg of
poli-dIdC, 20 mM HEPES pH 7.5, 50 mM KCl, 5% gly-
cerol, 0.175 mM EDTA) in a volume of 19 μl. Mixtures
were pre-incubated at 25 °C for 10 min. Then 162 μl of
the radiolabeled probe was added to each condition, and
the resulting mixture was incubated for 30 additional min
at 25 °C. For competition, 10 μg of CTCF nuclear extract,
followed by increasing amounts of competing extracts,
was added to the binding reaction. Then, the mixtures
were pre-incubated as previously described. For supershift
experiments, 1 μl of anti-CTCF mouse monoclonal anti-
body (BD Biosciences) or 1 μl of anti-actin (Santa Cruz,
sc-1616), used as a non-specific antibody, was added to
the binding reaction prior to the radiolabeled probe. Com-
plexes were analyzed by electrophoresis on a 4% polyacryl-
amide gel at 160 V for 2 h with 0.5×Tris-borate-EDTA
buffer. Gels were fixed using 10% acetic acid for 10 min
and then dried for 30 min using a Gel Dryer (Bio-Rad).
Radioactive complexes were revealed using a Molecular
Imager Fx (Bio-Rad).
Pathological analysis of ctcfl knockout mice
Testis weight was determined immediately after dissec-
tion. Weights were measured within the tunica albuginea,
excluding the cauda epididymis. Sperm analysis and
counts were performed as described [33]. The epididymis
was dissected and transferred into a small conical glass
grinder, and homogenized by hand. The total number of
sperm present in the epididymis was counted using a
Neubauer hemocytometer and a phase contrast micro-
scope (magnification 400×). At least 200 sperm in two dif-
ferent samples were counted. Fertility of mice was
determined by breeding the mice to multiple mates and
scoring the number of offspring.
Immunofluorescence and immunohistochemistry
techniques
For BrdU incorporation, mice were injected intraperitone-
ally with 1.2 μg BrdU. One hour after injection, testes
were dissected, fixed in 4% paraformaldehyde or Bouin,
paraffin embedded and sectioned. For H/E staining, Bouin
or PFA fixed testes were fixed overnight at 4 °C, washed
and dehydrated using ethanol and xylene, and embedded
in paraffin. Sections of 10 μm were cut, mounted on
SuperFrost Plus slides (Menzel-gläser), rehydrated and
stained with H/E.
For immunofluorescence analyses, Bouin or PFA fixed
and paraffin embedded testes were sectioned, treated
with the microwave (three times for 5 min, 750 W) in
10 mM NaCitrate buffer (pH 6.0) to expose antigens and
stained using standard procedures. Antibodies used: Rat
monoclonal anti-CTCFL (see abobe), PRSS50 (Abcam
49405) and STRA8 (Abcam 49405).Live imaging in seminiferous tubules
Imaging of testis tubules was performed as described
[33]. Briefly, testis were injected through the rete testis
with Hoechst 33342 and Trypan blue (Sigma) in 3–5 μl
of PBS, 1 h prior to testis dissection, to allow spreading
of the vital DNA stain throughout the adluminal com-
partment of the testis tubules and uptake by nuclei on
the adluminal side of the Sertoli cell barrier. Trypan blue
served as a marker for injected tubules. Individual sem-
iniferous tubules were isolated from testes using a col-
lagenase and hyaluronidase method, and Trypan blue
positive tubules were transferred into a drop of PBS +
with 0.2% BSA in a live-cell chamber overlaid with PBS-
saturated mineral oil. The testis tubules were examined
at 33 °C, using a Zeiss LSM510NLO confocal/multipho-
ton setup, to allow simultaneous acquisition of phase-
contrast, GFP and Hoechst images.
Additional file
Additional file 1: Movie S1. Live imaging of GFP-CTCFL. Ex vivo
confocal imaging of a live seminiferous tubule derived from a Ctcflgfp
knockin mouse. Images were acquired throughout tubules using a
combined multiphoton (Hoechst) and confocal laser (GFP) scanning
microscope setup. Images were assembled for 3D reconstruction
afterwards. The GFP-CTCFL fusion protein is shown in green. The DNA
stain Hoecht, which was injected at the adluminal site of the testis
tubule, is shown in red. Hoechst-positive cells represent Sertoli cells,
leptotene stage IX and later stage spermatocytes, and spermatids, all of
which are negative for GFP-CTCFL. Notice the presence of the
GFP-CTCFL-positive cells on one side (basal lamina) of the tubule.
Abbreviations
BrdU: bromodeoxyuridine; ChIP: chromatin immunoprecipitation;
DAB: diaminobenzidine; dCTP: deoxycytidine triphosphate;
dNTP: deoxynucleoside triphosphates; DTT: dithiothreitol;
EDTA: ethylenediaminetetraacetic acid; EMSA: electrophoretic mobility shift
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